Optimization of hyperthermia and dendritic cell immunotherapy for squamous cell carcinoma

Oncology Reports

Volumn 25, Issue 6, 2011, Pages 1525-1532

  Matsumoto, Koushi ^a   Yamamoto, Noriyuki ^a   Hagiwara, Sumitaka ^a   Saito, Masaki ^a   Furue, Hiroki ^a   Shigetomi, Toshio ^b   Narita, Yuji ^a   Mitsudo, Kenji ^c   Tohnai, Iwai ^c   Kobayashi, Takeshi ^d   Ueda, Minoru ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d CHUBU UNIVERSITY   (Japan)

Author keywords

Dendritic cell; Hyperthermia; Immunotherapy; Magnetite cationic liposome; Squamous cell carcinoma

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CELL MATURATION; CELL STRAIN; CELL STRAIN SCCVII; CELL THERAPY; CLINICAL EFFECTIVENESS; COCULTURE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEASIBILITY STUDY; HYPERTHERMIC THERAPY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; DENDRITIC CELLS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HSP70 HEAT-SHOCK PROTEINS; HYPERTHERMIA, INDUCED; IMMUNOTHERAPY; MICE; MICE, INBRED C3H;

EID: 79954531785     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1232     Document Type: Article

References (20)

1. Menoret A and Chandawarkar R: Heat-shock protein-based anticancer immunotherapy: an idea whose time has come. Semin Oncol 25: 654-660, 1998. (Pubitemid 28565546)
2. Nakajima M, Kuwano H, Miyazaki T, Masuda N and Kato H: Significant correlation between expression of heat shock proteins 27, 70 and lymphocyte infiltration in esophageal squamous cell carcinoma Cancer Lett 178: 99-106, 2002.
3. Basu S, Binder RJ, Ramalingam T and Srivastava PK: CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14: 303-313, 2001. (Pubitemid 32289294)
4. Melcher A, Todryk S, Hardwick N, Ford M, Jacobson M and Vile RG: Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat Med 4: 581-587, 1998. (Pubitemid 28237357)
5. Theriault JR, Mambula SS, Sawamura T, Stevenson MA and Calderwood SK: Extracellular HSP70 binding to surface receptors present on antigen presenting cells and endothelial/epithelial cells. FEBS Lett 579: 1951-1960, 2005.
6. Tanaka K, Ito A, Kobayashi T, et al: Intratumoral injection of immature dendritic cells enhances antitumor effect of hyperthermia using magnetic nanoparticles. Int J Cancer 116: 624-633, 2005. (Pubitemid 41099200)
7. Tanaka K, Ito A, Kobayashi T, et al: Heat immunotherapy using magnetic nanoparticles and dendritic cells for T-lymphoma. J Biosci Bioeng 100: 112-115, 2005. (Pubitemid 41569355)
8. Ostberg JR and Repasky EA: Emerging evidence indicates that physiologically relevant thermal stress regulates dendritic cell function. Cancer Immunol Immunother 55: 292-298, 2006. (Pubitemid 41682578)
9. Suzuki S, Narita Y, Yamawaki A, et al: Effects of extracellular matrix on differentiation of human bone marrow-derived mesenchymal stem cells into smooth muscle cell lineage: utility for cardiovascular tissue engineering. Cells Tissues Organs 191: 269-280, 2010.
10. Calderwood SK, Theriault JR and Gong J: How is the immune response affected by hyperthermia and heat shock proteins? Int J Hyperthermia 21: 713-716, 2005.
11. Inaba K, Inaba M, Romani N, et al: Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176: 1693-1702, 1992.
12. Shinkai M, Yanase M, Honda H, Wakabayashi T, Yoshida J and Kobayashi T: Intracellular hyperthermia for cancer using magnetite cationic liposome: in vitro study. Jpn J Cancer Res 87: 1179-1183, 1996. (Pubitemid 26420027)
13. Udono H and Srivastava PK: Comparison of tumor-specific immunogenicities of stress-induced protein gp96, hsp90, and hsp70. J Immunol 152: 5398-5403, 1994. (Pubitemid 24152988)
14. Khurana D, Martin EA, Kasperbauer JL, et al. Characterization of a spontaneously arising murine squamous cell carcinoma (SCCVII) as a prerequisite for head and neck cancer immunotherapy. Head Neck 23: 899-906, 2001. (Pubitemid 32862295)
15. Reis e Sousa C: Activation of dendritic cells: translating innate into adaptive immunity. Curr Opin Immunol 16: 21-25, 2004.
16. 't Hart BA and van Kooyk Y: Yin-Yang regulation of autoimmunity by DCs. Trends Immunol 25: 353-359, 2004.
17. Mukhopadhaya A, Mendecki J, Dong X, et al: Localized hyperthermia combined with intratumoral dendritic cells induces systemic antitumor immunity. Cancer Res 67: 7798-7806, 2007. (Pubitemid 47281374)
18. Hasday JD, Garrison A, Singh IS, et al: Febrile-range hyperthermia augments pulmonary neutrophil recruitment and amplifies pulmonary oxygen toxicity. Am J Pathol 162: 2005-2017, 2003.
19. Ellis GS, Carlson DE, Hester L, et al: G-CSF, but not corticosterone, mediates circulating neutrophilia induced by febrile-range hyperthermia. J Appl Physiol 98: 1799-1804, 2005. (Pubitemid 40570792)
20. Ito A, Shinkai M, Honda H, et al: Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles. Cancer Immunol Immunother 52: 80-88, 2003. (Pubitemid 36337615)